Standard chemotherapy with cetuximab for treatment of colorectal cancer
Author(s) -
Xin-Xiang Li,
Lei Liang,
Li-Yong Huang,
San-Jun Cai
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i22.7022
Subject(s) - cetuximab , medicine , kras , irinotecan , oncology , colorectal cancer , rash , regimen , hazard ratio , oxaliplatin , cancer , confidence interval
To review and assess the evidence related to cetuximab treatment in metastatic colorectal cancer (mCRC) with regard to KRAS status.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom